Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Nanalysis Scientific Corp. (V:NSCI)

Business Focus: Advanced Medical Equipment & Technology

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for NSCI within the last 6 months
See all filings within the past 6 months

Company News

May 14, 2020 21:41 ET
Nanalysis Announces New Board Member
CALGARY, May 14, 2020 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or "the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) announces today that Mr. Steve Meszaros has resigned from the company's board of directors for personal reasons, effective May 13, 2020. 
Read full article
Apr 23, 2020 06:18 ET
Nanalysis Scientific Corp. Reports Fourth Quarter and Annual 2019 Results
CALGARY, April 23, 2020 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) released its fourth quarter and annual 2019 results today.
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
May 15, 20201,460-85,074
Apr 30, 202086,53477,237
Apr 15, 20209,297-11,115
See Short Report

Business Summary

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology

Nanalysis Scientific Corp., formerly Canvass Ventures Ltd., is a Canada-based company that is engaged in the business of developing, manufacturing and selling portable nuclear magnetic resonance (NMR) spectrometers for the laboratory instrumentation market. The NMReady-60 is the fully-featured portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The NMReady-60 family of NMR spectrometers are used by chemical professionals in several industries including in oil and gas, chemical, pharma, biotech, food processing and also by the government and university labs.

See business summary



Search (past week) for $NSCI.CA NSCI.V

  • No tweets found